COVID-19

better trustworthiness of clinical evidence through clinical trials and systematic reviews

Autores

Downloads

Não há dados estatísticos.

Biografia do Autor

Álvaro Nagib Atallah, Department of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de São Paulo

MD, PhD. Full Professor and Head of the Discipline of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de São Paulo (UNIFESP), and Director of Cochrane Brazil, São Paulo (SP), Brazil.

Referências

Althouse AD. How Did This Pass Peer Review? Thoughts on the Lancet and NEJM COVID-19 Retractions. Medscape. 2020. Available from: Available from: https://www.medscape.com/viewarticle/932262 Accessed in 2020 (Jun 18).

Chatterjee P, Anand T, Singh KJ, et al. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian Journal of Medical Research. [Epub ahead of print]. Available from: Available from: http://www.ijmr.org.in/preprintarticle.asp?id=285520 Accessed in 2020 (Jun 18).

Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-8. PMID: 32286245; doi: 10.1515/cclm-2020-0369.

Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202-5. PMID: 32217834; doi: 10.1172/JCI137647.

Randomised Evaluation of COVID-19 Therapy (RECOVERY). University of Oxford; 2020. Available from: Available from: https://clinicaltrials.gov/ct2/show/NCT04381936 Accessed in 2020 (Jun 18).

Downloads

Publicado

2020-06-04

Como Citar

1.
Atallah Álvaro N. COVID-19: better trustworthiness of clinical evidence through clinical trials and systematic reviews. Sao Paulo Med J [Internet]. 4º de junho de 2020 [citado 14º de março de 2025];138(3):171-3. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/604

Edição

Seção

Editorial